Intracoronary stem-cell injection after myocardial infarction: Microcirculation sub-study

Arquivos Brasileiros de Cardiologia

Volumn 97, Issue 5, 2011, Pages 420-426

  Moreira, Rodrigo de Carvalho ^a,b,c   Haddad, Andréa Ferreira ^a,b,c   Silva, Suzana Alves ^a,b,c   Souza, André Luiz Silveira ^a,b,c   Tuche, Fábio Antônio Abrantes ^a,b,c   de Oliveira, Mônica Amorim ^a,b,c   Mesquita, Cláudio Tinoco ^a,b,c   Rochitte, Carlos Eduardo ^a,b,c   Borojevic, Radovan ^a,b,c   Dohmann, Hans Fernando Rocha ^a,b,c  

^a HOSPITAL PRÓ CARDÍACO   (Brazil)

^b Secretaria Municipal de Saude e Defesa Civil do Rio de Janeiro   (Brazil)

^c Excellion Serviços Biomédicos AS   (Brazil)

Author keywords

Autologous; Bone marrow cells; Myocardial infarction therapy; Stem cell transplantation method; Transplantation

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BONE MARROW MONONUCLEAR CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION; HEART PERFUSION; HUMAN; INTRACORONARY STEM CELL INJECTION; MALE; MICROCIRCULATION; MONONUCLEAR CELL; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STEM CELL TRANSPLANTATION;

BONE MARROW TRANSPLANTATION; CORONARY VESSELS; FEMALE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; TECHNETIUM TC 99M EXAMETAZIME;

EID: 84455175870     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000095     Document Type: Article

References (22)

1. Sutsch G, Kiowski W, Bossard A, Luscher TF, Maier W, Vogt P, et al. Use of an emboli containment and retrieval system during percutaneous coronary angioplasty in native coronary arteries. Schweizerische medizinische Wochenschrift. 2000;130(33):1135-45.
2. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93(2):223-8.
3. Claeys MJ, Bosmans J, Veenstra L, Jorens P, De Raedt H, Vrints CJ. Determinants and prognostic implications of persistent ST-segment elevation after primary angioplasty for acute myocardial infarction: importance of microvascular reperfusion injury on clinical outcome. Circulation. 1999;99(15):1972-7.
4. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol. 2000;36(4):1202-9.
5. Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, et al. Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet. 2006;367(9505):113-21.
6. Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, et al. Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation. 2005;112(9 Suppl):I150-6.
7. Fearon WF, Ikeno F, Bailey LR, Hiatt BL, Herity NA, Carter AJ, et al. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein. Catheter Cardiovasc Interv. 2004;61(3):422-8.
8. Murad-Netto S, Moura R, Romeo LJM, Manoel Neto A, Duarte N, Barreto F, et al. Terapia de células-tronco no infarto agudo do miocárdio, através de perfusão coronariana retrógrada: uma nova técnica. Arq Bras Cardiol. 2004;83(4):349-51.
9. Liu L, Kubes P. Molecular mechanisms of leukocyte recruitment: organ-specific mechanisms of action. Thromb Haemost. 2003;89(2):213-20.
10. Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr. 2001;126(34-35):932-8.
11. Samoto VY, Branco ER, Ferreira G. Padrão de distribuição de células mononucleares da medula ósseaem tecido cardíaco sadio por diferentes vias de infusão. Rev Bras Cardiol Invas. 2009;17(2):220-6.
12. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation. 1998;98(10):1006-14.
13. Mesquita CT, Correa PL, Felix RC, Azevedo JC, Alves S, Oliveira CC, et al. Autologous bone marrow mononuclear cells labeled with Tc-99m hexamethylpropylene amine oxime scintigraphy after intracoronary stem cell therapy in acute myocardial infarction. J Nucl Cardiol. 2005;12(5):610-2.
14. Lu M, Zhao S, Liu Q, Jiang S, Song P, Qian H, et al. Transplantation with autologous mesenchymal stem cells after acute myocardial infarction evaluated by magnetic resonance imaging: an experimental study. J Thorac Imaging. 2011 Feb 17 [Epub ahead of print].
15. Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J. 2006;27(9):1114-22.
16. Penicka M, Widimsky P, Kobylka P, Kozak T, Lang O. Images in cardiovascular medicine: early tissue distribution of bone marrow mononuclear cells after transcoronary transplantation in a patient with acute myocardial infarction. Circulation. 2005;112(4):e63-5.
17. Seeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28(6):766-72.
18. Spevack DM, Cavaleri S, Zolotarev A, Liebes L, Inghirami G, Tunick PA, et al. Increase in circulating bone marrow progenitor cells after myocardial infarction. Coron Artery Dis. 2006;17(4):345-9.
19. Silva SA, Sousa AL, Haddad AF, Azevedo JC, Soares VE, Peixoto CM, et al. Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. Cell Transplant. 2009;18(3):343-52.
20. Nogueira FB, Silva SA, Haddad AF, Peixoto CM, Carvalho RM, Tuche FA, et al. Função sistólica de pacientes com infarto miocárdico submetidos a transplante autólogo da medula óssea. Arq Bras Cardiol. 2009;93(4):374-9.
21. Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther. 2011;129(1):97-108.
22. Mosna F, Annunziato F, Pizzolo G, Krampera M. Cell therapy for cardiac regeneration after myocardial infarct: which cell is the best? Cardiovasc Hematol Agents Med Chem. 2010;8(4):227-43.